Summary. -Coxiella burnetii is the etiological agent of the zoonosis Q fever, which can cause an acute or a chronic, life-threatening disease in humans. It presents a highly stable cell form, which persists in the environment and is transmitted via contaminated aerosols. Ruminants are considered as the main reservoir for human infections but are usually asymptomatic. Subclinical infection in these animals and the occurrence of serologically negative shedders hamper the identification of infected animals with the currently used diagnostic techniques. This suboptimal sensitivity limits reliable identification of infected animals as well as the well-timed implementation of countermeasures. This review summarizes compounds, focusing on C. burnetii seroreactive proteins, which were discovered in recent immunoproteomic studies. We analyzed these proteins regarding their localization, function, frequency of citation, differences seen in various host species as well as sensitivity and specificity. Finally, proteins useful for the development of new diagnostic test systems as well as subunit vaccines were discussed. 
Introduction
Coxiella burnetii is the etiological agent of the zoonosis Q fever, which has been reported worldwide. This gramnegative bacterium forms a small cell variant that can be transmitted via contaminated aerosols. The organism is considered as one of the most infectious agents for humans with an ID 50 = 1 (Vigil et al., 2010) . It replicates within eukaryotic cells in a progressing phagolysosome-like parasitophorous vacuole at acidic pH 5 . Because C. burnetii is highly stable and can remain infectious in the environment for an extended period of time, it was classified by the Centers for Disease Control, USA as a category B bioterrorism agent (Vigil et al., 2010) .
In humans, C. burnetii presents in 40% of cases as an acute and often self-limiting, febrile illness with severe headaches, fever or pneumonia. In 1-5% of primary infections, chronic Q fever may develop, which can be life-threatening and often presents as endocarditis (Maurin and Raoult, 1999; Landais et al., 2007; Kampschreur et al., 2014) . In the EU countries, 648 and 833 human Q fever cases were reported in and 2015 , respectively (ECDC/EFSA report, 2015 . However, during a massive epidemic that occurred in the Netherlands between 2007 and 2010, over 4000 acute and 284 chronic (mortality rate of 19%) human cases were recognized (Kampschreur et al., 2010 (Kampschreur et al., , 2014 . These numbers illustrate that the infection has a major public health impact and it can re-emerge anytime from the endemic state into an outbreak of an unexpected dimension.
Ruminants are considered as the main reservoir for Q fever in men. In these animals, an infection is usually asymptomatic or may manifest as late term abortions or weak offspring. C. burnetii is massively shed in birth or abortion products, but also in milk, feces, and urine (Arricau-Bouvery et al., 2003; Rodolakis et al., 2007; Rousset et al., 2009 ). Due to the subclinical infection and unnoticed shedding that can be continuous or intermittent (Barlow et al., 2008; Boarbi et al., 2014) , identification of the source of infection is usually problematic. Furthermore, the veterinary Q fever serodiagnostics have limited sensitivity. It was demonstrated to be 86% for milk samples and 84% for blood samples from cattle (Paul et al., 2013) , or as low as 58% for milk samples from goats (Hogerwerf et al., 2014) . Thus, it is not surprising that independent studies described the occurrence of serologically negative shedders. Ruminants with normal parturition can shed the bacterium via the milk or vaginal mucus even while specific antibodies are not detectable (Rousset et al., 2009; Bottcher et al., 2011; Niemczuk et al., 2014; Bauer et al., 2016) . It was shown that at least 24% of these seronegative aborting and non-aborting goats shed the microorganism (Rousset et al., 2009) .
Like members of Enterobacteriaceae, C. burnetii exhibits a lipopolysaccharide (LPS) phase variation. Virulent phase I bacterium expresses a full-length, smooth LPS, whereas avirulent phase II exhibits a severely truncated, rough LPS, that develops after frequent passaging in immunoincompetent hosts (Raoult and Parola, 2007) . For routine veterinary diagnosis IgG-based Q fever ELISA kits, containing mixed corpuscular antigens of C. burnetii phase I and II, are employed. These antigens are not well defined and might not be accessible to antibodies in the test systems. Antigenic variation among C. burnetii isolates may also contribute to suboptimal test sensitivity (Beare et al., 2009) . It was demonstrated by comparison of the commercial with experimental phase-specific ELISAs that 45% of sera are only phase II positive but phase I negative. Thus, these sera cannot be diagnosed as Q fever positive by commercial ELISA kit (Bottcher et al., 2011) .
The whole cell antigens may contain many conserved proteins, which can impair specificity through cross-reactions with other bacterial pathogens, such as Bartonella spp., Legionella spp. and Chlamydia spp. (La Scola and Raoult, 1996; Musso and Raoult, 1997; Lukacova et al., 1999) . This finding might relay to a comprehensive study of the large Dutch outbreak, which has shown only 52% specificity of a commercial ELISA (Hogerwerf et al., 2014) . A further drawback of currently used serodiagnostics is the inability to differentiate between recent and past infections or between infected and vaccinated animals (Horigan et al., 2011) . Therefore, efforts have to be made to improve uniformity, sensitivity, and specificity of the diagnostic kits by replacement of the currently used corpuscular whole cell antigens with well-defined antigens like immunogenic proteins. These compounds might be also beneficial for the development of a subunit vaccine (ArricauBouvery et al., 2005; O'Neill et al., 2014) .
This review gives an overview of C. burnetii seroreactive proteins described in recent immunoproteomic studies. We analyzed the identified proteins regarding their localization, function, the frequency of detection, differences seen in various host species as well as sensitivity and specificity. Finally, we discussed proteins which might be useful in diagnostic or subunit vaccine development.
Selection of immunoproteomic publications
The comprehensive literature search was performed using PubMed (https://www.ncbi.nlm.nih.gov/pubmed) as the main source of studies on C. burnetii. Nineteen articles focussing on the identification of immunoreactive proteins which were published since 2004 were analyzed. These publications are listed in Table 1 together with their basic characteristics, like the method of identification, species involved, and number of sera evaluated. The publications comprise eleven and four investigations, solely based on human and mice sera, respectively, and three studies that analyzed human and mice sera in parallel using the same techniques. Thus, fourteen articles investigated the reactivity of human, seven mice, and one guinea pig sera. Interestingly, one of the selected studies employed two different experimental procedures for evaluating the same human sera (Xiong et al., 2012a) . On the other hand, we excluded a publication describing a frequently published antigen which was recognized by sera from experimentally and naturally infected goats, since it did not report a screening method (Fernandes et al., 2009) .
Most of the studies used 2-dimensional gel electrophoresis followed by Western blotting for identification of reactive proteins. Other frequent methods are protein microarrays comprising up to 2000 C. burnetii open reading frames (ORFs) and ELISA. The latter is also used to validate results from experimental screening and to determine sensitivity and specificity of particular antigens. Western blot-like immunostrips have also been used to validate the obtained results (Vigil et al., 2010) . Interestingly, a unique procedure based on immunocapturing of antigens on biofunctionalized magnetic microspheres using polyclonal antibodies was presented by Flores-Ramirez et al. (2016) . In most of these articles total protein extracts were analyzed, but few studied bacterial protein fractions enriched for outer membrane proteins (Papadioti et al., 2011; Jiao et al., 2014) . These outer membrane proteins were found to be advantageous for the development of new vaccines due to their exposition to host immune cells (Hotta et al., 2004; Papadioti et al., 2011) .
Description of the identified immunoreactive proteins
In the 19 selected publications 169 immunoreactive proteins were described (Supplementary Table 1 ). At first, the cellular localization and function of these proteins were Pool of 3 sera, also for negative control n.s. = not stated, NM = Nine Mile, Se. = sensitivity, Sp. = specificity.
Fig. 1
Localization of identified C. burnetii antigens based on annotations in the respective publication The functions of 43% of all identified proteins are stated in the publications as either known or predicted by defined algorithms, such as PSORTb 3.0.2 or SOSUI-GramN Jiao et al., 2014; Flores-Ramirez et al., 2016) . The remaining 57% are classified as proteins with unknown localization, or it was not stated.
analyzed. Based on gene annotations and in silico predictions presented in the respective publication we concluded, that only 43% of all identified proteins have a known or predicted localization ( Fig. 1) . Because some authors have suggested that surface exposition might increase the chance for recognition by immune cells (Hotta et al., 2004; Papadioti et al., 2011) , we assumed that outer membrane proteins would dominate. Surprisingly, the majority of the identified proteins are located in the cytoplasm (27%), followed by proteins associated with the inner (8%) or outer membrane (7%). Only one periplasmatic protein (1%) and one secreted protein (1%) were noted in the selected publications. Also, Jiao et al. (2014) who analyzed protein fractions enriched for surfaceexposed antigens have revealed various cytoplasmic bacterial proteins. Subsequently, they concluded that besides technical reasons the identified cytoplasmic proteins might reside on the surface of C. burnetii and contribute to bacterium-host interactions. This observation was already described for other bacteria. For instance, the cytoplasmic aminopeptidase of Rickettsiae was detected in the outer membrane fraction of Anaplasma marginale (Santhanagopalan et al., 2006) , and the cytoplasmic disulfide oxidoreductase was present on the surface of Ehrlichia chaffeensis (McBride et al., 2002) . In Staphylococcus aureus, the cytoplasmic ATP-synthase F1 α and β subunits are located in the cell envelope (Gatlin et al., 2006) . Thus, we can legitimately speculate that the cytoplasmic seroreactive C. burnetii proteins may perform some additional moonlighting activities on the bacterial surface next to their cytoplasmic functions.
The annotated functions, which were available for approximately 50% of the identified proteins, were also evaluated (Fig. 2) . The known or predicted roles of the proteins are evenly distributed among twelve categories with a slight preference for proteins involved in general metabolic pathways, such as energy production and conversion (13.6%). The second frequent class comprises enzymes involved in gene expression processes -transcription, translation and ribosomal structures (9.5%), followed by substrates (7.0%) of the type IV secretion system (T4SS). This observation underlines the hypothesis of Xiong et al. (2016) who noticed, that T4SS substrates are probable targets for the immune Function of identified C. burnetii antigens based on annotations in the respective publication The functions of more than half of all identified proteins are stated within the publications. Most were derived from COG or UniProt databases (Flores-Ramirez et al., 2016) as marked in Table 2 . The remaining proteins are classified as proteins with unknown functions or functions were not stated. system due to the cytosolic localization within the host and consequently have a high potential for major histocompatibility complex (MHC) l presentation to activate cytotoxic (CD8+) T cells. These T cells serve for an effective elimination of cells infected with intracellular bacteria even if they reside in phagosomes as it was described for Salmonella typhimurium and Mycobacterium tuberculosis (Harty and Bevan, 1999) . Proteins that have chaperone activity or mediate posttranslational modifications also tend to be immunogenic (6.5% of the reviewed proteins). Less represented groups of proteins can be related to the T4SS apparatus, sensor activity and stress response, cell division, DNA recombination and repair, cell wall biogenesis and integrity or ankyrin repeat domains, motility and DNA transposition.
The majority of immunogenic proteins seems to have housekeeping functions such as metabolism, gene expression, protein synthesis and DNA replication. Therefore, we speculate that these proteins might be the most presented antigens to immune cells due to high abundance during activated metabolism. This assumption is in good agreement with the result of Xiong et al. (2012a) who evaluated potential serodiagnostic markers for Q fever and identified 13 proteins with housekeeping function out of 20 antigenic proteins. They discovered that proportionally more of these proteins are recognized by the sera from patients with acute rather than with chronic or persistent infections. Apparently, the persistence of C. burnetii in patients with chronic Q fever is associated with unresponsiveness of lymphocytes due to a lack of macrophage activation (Koster et al., 1985; Stein et al., 2000) .
Comparison of antigenic profiles between the replicative large cell variants (LCVs) and metabolically dormant SCVs showed that the immunogenic proteins CBU1718, CBU0236, CBU0867, CBU1433, CBU0528, CBU0963, CBU1385, CBU0737 and CBU1416 are more abundant in LCVs (Ihnatko et al., 2012; Papadioti et al., 2012) . Noticeably, eight of the nine antigens are involved in transcription, translation, chaperone or protein secretion activities. These findings confirm that the metabolically active LCVs are expressing housekeeping proteins that seem to be recognized by the immune cells.
Interestingly, among the identified immunoreactive proteins many virulence associated factors were described. The CBU0630 may play a role in survival and multiplication within the host cell, and it might be essential for cell entry (Ihnatko et al., 2012) . Similarly, CBU1260 (OmpA) was shown to be involved in invasion as its mutation strongly inhibits C. burnetii internalization and replication within host cells (Martinez et al., 2014) . Furthermore, CBU0612 (OmpH) is probably a major factor for adhesion to host cells (Sekeyova et al., 2009 ) and the CBU0630 (MIP) is associated with macrophage infectivity (Flores-Ramirez et al., 2016) . In addition, CBU1967 and CBU1697 are classified (PATRIC, https://www.patricbrc.org) as multidrug resistance transporters of the Bcr/CflA family. Ankyrin-repeat domain proteins also play a role in the virulence mechanisms of Table 1 and Supplementary Table 1 were counted either for all 169 proteins (a), 132 proteins reactive with human sera (b) or 64 proteins reactive with mouse sera (c).
C. burnetii. They mimic eukaryotic proteins and modulate host cell processes including cell survival, signaling and vesicular trafficking (Brüggemann et al., 2006) . It was suggested that they are candidate T4SS substrates, which are secreted into the host cytosol Voth et al., 2009) . Interestingly, five immunogenic proteins have also an antioxidant function (CBU0963, CBU1278, CBU1477, CBU1706, CBU1708), which may be crucial for survival within the acidic vacuole, the intracellular niche of C. burnetii.
Frequency of identified C. burnetii immunogens
Described seroreactive proteins vary drastically in their frequency of identification. Fig. 3a illustrates how many proteins have been identified in one, two or more immunoproteomic studies. Surprisingly, only a few proteins were found in more than two publications, indicating that there is no uniform pattern of antigens, even within individuals of the same host species. Most of the 169 C. burnetii immunodominant proteins (Supplementary Table 1) identified by screening with human, mouse, and guinea pig sera were published in only one or two studies (83%). However, 20 identified proteins were found frequently, in at least four or more publications. These proteins are listed in Table 2 with their characteristic features, including the strength of reactivity with selected sera, as well as sensitivity and specificity for detection of C. burnetii positive sera. According to the presented data, only five proteins (3%) were identified in at least half of the 19 publications (Table 1 and 2). The strongest immunodominant proteins are CBU0612 (OmpH), CBU0092 (YbgF), CBU0236 (Tuf-2), CBU1718 (GroEL), and CBU1910 (Com1) which were mentioned in 9, 10, 11, 16, and 17 publications, respectively.
The differences in the immune system among the three analyzed host species are eventually responsible for the heterogeneity of antigen detection. Thus, we can assume, that the number of immunogenic proteins recognized more frequently will be higher if only one host species is analyzed. However, investigation of 14 publications that studied human sera (Table 1) has shown a similar frequency of antigen identification as mentioned above (Fig. 3b) . From 132 proteins that react with human sera, 86% are found only in one or two studies. Similarly, approximately 2% are found in at least half of the 14 selected publications. CBU0236 (Tuf-2) was mentioned in eight, CBU1910 (Com1) in nine, and CBU1718 (GroEL) in ten articles. The seven publications using mice sera from two strains of genetically identical mice have also resulted in the identification of proteins that are rarely present in more than two studies (Fig. 3c) . From the total of 64 immunogenic proteins recognized by mouse sera, 88% were identified only in one study, while 2% were present in more than a half of the selected publications. Repeatedly, CBU1910 (Com1) and CBU1718 (GroEL) were most frequently found. These antigens were also targeted in the guinea pig (Deringer et al., 2011) and cattle studies (Vigil et al., 2010) . Kowalczewska et al. (2011) described these immunodominant proteins as the most versatile markers of Q fever. Wang et al. (2013) proposed that CBU1718 is an excellent molecular marker for serodiagnosis of both, acute and chronic Q fever. Furthermore, CBU1910 was suggested to be a key antigen, which may induce protective immunity (Xiong et al., 2012b) . The next most frequently described C. burnetii antigen, CBU0236 (Tuf-2) is a candidate marker of acute (a) (b) (c) Fig. 4 Distribution of C. burnetii immunogenic proteins between species-specific and common antigens (a) The Venn diagram comprises all immunogenic proteins identified in studies 1 to 19 listed in Table 1 . For each species, varying numbers of proteins were identified, illustrated by the different circle sizes: 132 proteins are seroreactive in humans versus 64 and 29 seroreactive proteins in mice and guinea pigs. The ratios are related to the total number of found proteins in the respective host species. The ratios for proteins that are recognized by two or all three host species (illustrated by shared areas) are shown for each host species. The numbers in brackets indicate absolute protein numbers. (b) The Venn diagram comprises immunogenic proteins identified in publications 16, 17 and 18 as listed in Table 1 , that analyzed human and mouse sera in parallel with the same techniques (Xiong et al., 2012a; Wang et al., 2013; Jiao et al., 2016) . In total 58 proteins were identified and the ratios for antigens found exclusively in humans, mice or both were averaged. Bold ratios are related to all proteins from the three studies and the others refer to the total number in the respective host species. Q fever (Kowalczewska et al., 2011) . Similarly, CBU0092 (YbgF) was proposed to be a phase II specific marker that can be employed for early diagnosis of acute infection (Kowalczewska et al., 2012) . It was also supposed as essential for protective immunity (Vigil et al., 2011) . CBU0612 (OmpH) is also a promising candidate marker for acute and chronic Q fever (Kowalczewska et al., 2011) . It may be important for adhesion to host cells (Sekeyova et al., 2009) and for induction of a protective immunity (Vigil et al., 2011) .
Despite extensive genomic plasticity and diversity among potential effector proteins described by Beare et al. (2009) , sequence analyses of all 169 identified immunogenic proteins showed identical protein sequences between all published strains (data not shown). Thus, the presence of strain-specific antigens of C. burnetii can probably be excluded, despite the possibility of posttranslational modifications. It rather seems that the bacterium lacks active antigenic proteins which may induce a conserved immune response or produce molecules that can inhibit it. Indeed, Shannon et al. (2005) have identified significant differences in human dendritic cell (DC) activation between C. burnetii phase I and II. Infection with the virulent phase I cells did not induce activation of DC in contrast to infection with the avirulent phase II. The latter has resulted in 10-fold higher IL-12 and tumor necrosis factor (TNF) production. Thus, the authors proposed that full-length LPS of phase I may mask the toll-like receptor (TLR) ligands from innate immune cells allowing C. burnetii replication without inflammatory response in immune competent hosts (Shannon et al., 2005) . The bacterium directly limits inflammasome activation (Cunha et al., 2015) and proinflammatory response of primary bovine macrophages by inhibition of translation and release of IL-1β. C. burnetii also restricts stimulation of the increased expression of the activation markers CD40, CD80 and CD86, and MHC molecules in these cells (Sobotta et al., 2016) . Besides inhibition of the inflammatory response, C. burnetii prevents host cell apoptosis Lührmann and Roy, 2007; Klingenbeck et al., 2013; Eckart et al., 2014) . This mechanism ensures survival within host cells and leads to a restriction in antigen uptake or presentation of bacterial proteins to surrounding innate immune cells. Thus, C. burnetii is a highly specialized organism which can subvert host cell functions by prevention of TLR recognition, inhibition of apoptosis and inflammation as well as modulation of diverse vesicle traffic pathways (Cunha et al., 2015) . We can conclude that these evasion strategies probably account for the inconsistent seroreactivity of most identified C. burnetii antigens as it is evident from the huge fraction of proteins found once.
(a) (b)
Host species-specific and common C. burnetii antigens
The distribution of all identified immunogenic proteins among the host species is demonstrated in Fig. 4a . The number of determined reactive proteins varies drastically from 132 that were recognized by human sera versus 62 and 29 with mice and guinea pig sera, respectively. Due to these discrepancies, the ratios of antigens found either solely in one, two or all three species are related to the total number of identified proteins in the respective species. The majority (65%) of immunogenic proteins identified with human sera is found only in human sera, while 21% and 6% are also recognized by mouse or guinea pig sera, respectively. Only 8% are shared by all three host species. Thus, most of C. burnetii antigens recognized by humans are apparently not common with antigens causing a response in mice or guinea pigs. The species-specific antigenic response may arise from differences in immune systems as these vary significantly in humans and mice (Mestas and Hughes, 2004) . Different infection stages, as well as, individual variabilities may also contribute to differences in antibody generation.
A more precise conclusion about the portion of host species-specific anti-C. burnetii antigen responses can be drawn from those three publications, which analyzed human and mouse sera in parallel using the same techniques (Xiong et al., 2012a; Wang et al., 2013; Jiao et al., 2014; Ref. 16-18, Table 1 ). In this case, the ratios can be related to the total number of proteins (Fig. 4b) . The 58 identified immunoreactive proteins were used for calculating the ratios of proteins exclusively found in human, mouse or the both sera. Approximately half (48%) of the total proteins found are recognized by human and mouse sera, particularly 66% in the publication of Xiong et al. (2012) , 44% in Wang et al. (2013) and 41% in Jiao et al. (2014) . These common antigens represent very promising immune targets for sensitive Q fever detection in various hosts, including humans and ruminants.
Sensitivity and specificity of identified immunogenic proteins
In some of the selected immunoproteomic studies, sensitivity and specificity of ELISAs based on seroreactive proteins were analyzed (Beare et al., 2008; Chen et al., 2009; Sekeyova et al., 2010) or protein microarrays (Xiong et al., 2012a) . Sensitivity ranged from 40% to 60%. However, there are some proteins which are connected with very low sensitivity (8.3% for CBU1628 and 11.6% for CBU1627) (Beare et al., 2008) . This is in agreement with the rare presence in the 19 selected studies (Supplementary Table 1) . On the other hand, there are also some proteins which are connected to very high sensitivity such as CBU1718 (GroEL) with 88% (Xiong et al., 2012a) and CBU0092 (YbgF) with 72% (Sekeyova et al., 2010) . These exceptionally high values correlate with the frequency of citations as they belong to the most often identified proteins (Table 2) .
Regarding the specificity of tests, some of the immunodominant proteins including the most frequently published antigens, like CBU1718 (GroEL), CBU0236 (Tuf-2), CBU1398 (SucB), CBU1290 (DnaK) and CBU0235 (FusA) are highly conserved among bacteria species (Ihnatko et al., 2012) . This correlates with their housekeeping functions (Table 2) . Also, CBU0612 (OmpH), which belongs to the most often identified antigens is described as widely distributed in various bacteria (Sekeyova et al., 2009) . Majority of the most immunogenic C. burnetii antigens tend to be conserved proteins and are surely also immune targets in other bacterial species. This makes their application for detection of C. burnetii-specific epitopes difficult. For example, rabbit C. burnetii phase II polyclonal antisera reacted with recombinant Bartonella CBU1398 (SucB), a highly conserved enzyme of the TCA cycle (Gilmore et al., 2003) .
Immunoproteomic studies that compared reactivity of single proteins with sera from Q fever patients and other infections revealed significant differences. Xiong et al. (2012a) analyzed the major reactive proteins in humans, CBU1718 (GroEL), CBU0092 (YbgF), CBU0229 (RipL), CBU0630 (Mip), CBU0612 (OmpH), CBU1910 (Com1) and CBU1290 (DnaK) with sera of patients with rickettsial spotted fever, streptococcal pneumonia or Legionella pneumonia. The proteins showed moderate cross-reactivity with Q fever patient sera. Thus, a combination of antigens was suggested to enhance sensitivity and specificity of detection (Xiong et al., 2012a) . In another study eight from 16 surface-exposed C. burnetii antigens (CBU0067, CBU0227, CBU0630, CBU1078, CBU1290, CBU1385, CBU1594 and CBU1706) reacted significantly higher with Q fever sera from mice than with sera of mice infected with Rickettsia rickettsia, R. heilongjiangensis or R. typhi . These results make particular seroreactive proteins promising molecules for Q fever detection in humans without significant crossreactions from related bacteria and pathogens causing similar symptoms.
Regarding the cross-reactivity with naïve sera, one study shows that most identified proteins (13 of 21 proteins) were Q fever-specific: CBU1910, CBU0891, CBU0109, CBU1143, CBU0612, CBU0092, CBU0545, CBU1398, CBU0630, CBU1513, CBU1719, CBU0229 and CBU0653 (Vigil et al., 2010) . Nearly half of them belong to the most frequently reactive antigens confirming their diagnostic potential.
Thus, the mentioned publications demonstrate the suitability of many identified immunogenic proteins for specific detection of Q fever. 
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Candidate proteins for new vaccines
Identification of immunodominant proteins is not only required for the improvement of diagnostics, but also for the development of subunit vaccines. For an effective immunity against C. burnetii, both the humoral and cellular immune response, and especially their interplay with CD4+ T cells are needed (Zhang et al., 2004b and Andoh et al., 2007; Chen et al., 2011) . Naïve mice that received serum from vaccinated mice were protected against C. burnetii challenge as stated by Vigil et al. (2011) . Also, a cellular immune response contributes to protective immunity. Adoptive transfer of CD8+ and CD4+ T cells conferred measurable protection against C. burnetii challenge (Xiong et al., , 2016 Zhang et al., 2007) . C. burnetii causes death in the SCID and T cell deficient mice, but not in B cell deficient mice. Therefore, T cells seem to be essential for Q fever immunity (Andoh et al., 2007) .
The following immunogenic proteins were described to have a potential as candidates for subunit vaccines: CBU0311 (P1) (Ihnatko et al., 2012) , CBU1910 (Com1), CBU0092 (YbgF), CBU0612 (OmpH), CBU0891, CBU1143 (YajC) and CBU0545 (LemA) (Vigil et al., 2011) . To confirm their potential as a vaccine, mouse bone marrow-derived dendritic cells were stimulated with recombinant proteins and transferred into naïve mice before C. burnetii challenge. Com1 (CBU1910) and Mip1 (CBU0630) in contrast to GroEL (CBU1718) were identified as key antigens to induce a protective immune response and to stimulate IFN-γ producing CD4+ (Th1) and CD8+ (Tc1) T cells (Xiong et al., 2012b) .
In another study, CD4+ T cell epitope peptides derived from major immunodominant proteins were investigated in mice resulting in a pool of seven peptides that conferred significant resistance to C. burnetii challenge . This confirms the importance of protein or peptide combinations not only for sensitive Q fever diagnostic but also for the development of an effective vaccine. Moreover, 29 C. burnetii CD8+ T cell peptide epitopes were delivered via expression in a Listeria monocytogenes strain for cytosol targeting and induced strong CD8+ T-cell IFN-γ recall responses after infection as well as measurable protection in vivo (Xiong et al., 2016) . Thus, these in vivo experiments emphasize, that stimulation of B and T (CD4+ and CD8+) cells confer protection against C. burnetii challenge. 
Conclusion
Altogether 169 C. burnetii antigenic proteins were identified in the 19 immunoproteomic studies published during the last two decades. Twenty of these proteins are shown as the most frequently recognized antigens by human, mouse or guinea pig sera. CBU1910 (Com1), CBU1718 (GroEL), CBU0236 (Tuf-2), CBU0092 (YbgF) and CBU0612 (OmpH) were highlighted as immunodominant markers that might serve as promising candidates for better diagnostic tools and vaccines. Since sensitivity and specificity of tests are essential characteristics, we stress the importance of combining specific proteins and peptides for a robust Q fever detection. 
